KALV- Kalvista Pharmaceuticals, Inc.

Name: Kalvista Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 30 sells. KALV is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Palleiko Benjamin L	462.6K	$12.49M	-
Other	Yea Christopher	223.5K	$6.03M	-
Other	Audhya Paul K.	142.5K	$3.85M	-
Other	Arif Bilal	100.0K	$2.70M	-
Other	Sweeny Nicole	51.4K	$1.39M	-

Activity

Buys and sells only

Transactions

10 filings · page 14

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 29, 2021	Maetzel Andreas73	Senior Vice President, Medical	Sale+OE	88,030	$25.28	$2,225,736.32	-70.7%	-15.6%	-49.5%
Apr 28, 2021	Smith Michael David	Senior VP, Development	Sale+OE	10,014	$25.76	$257,982.67	-100%	-20.1%	-49.9%
Apr 1, 2021	Crockett Thomas Andrew72	CEO	Sell	10,000	$27.44	$274,436.23	-2.0%	-12.7%	-45.4%
Feb 23, 2021	Crockett Thomas Andrew72	CEO	Sell	10,000	$33.55	$335,538.32	-1.4%	-	-
Feb 23, 2021	Yea Christopher53	Chief Development Officer	Sell	15,000	$33.59	$503,877.32	-6.7%	-	-
Feb 23, 2021	Palleiko Benjamin L46	CFO, Cbo &Secretary	Sale+OE	29,642	$33.59	$995,561.82	-9.1%	-	-
Feb 23, 2021	Feener Edward P.72	Chief Scientific Officer	Sell	31,000	$33.60	$1,041,642.41	-10.9%	-	-
Jan 4, 2021	Crockett Thomas Andrew72	CEO	Sell	10,000	$18.19	$181,904.14	-2.6%	-	-
Dec 30, 2020	Palleiko Benjamin L46	CFO, Cbo &Secretary	Sale+OE	358	$20.04	$7,174.79	-1.1%	-	-
Nov 2, 2020	Feener Edward P.72	Chief Scientific Officer	Sell	6,000	$17.14	$102,811.80	-7.6%	-	-

← PrevPage 14Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC